W. Richey Neuman

Statistics

Publications

Citations

142

H-Index

Active since

2011

Affiliations

Portola Pharmaceuticals (United States)(Current)

Ochsner Medical Center

University of California, Irvine

W. Richey Neuman is an author at Portola Pharmaceuticals (United States) specializing in thrombosis prevention, thrombosis, and thromboembolism prevention.

Publications per year

2011–2019

Publications

A retrospective study to describe the incidence of moderate to severe allergic reactions to factor IX in subjects with haemophilia B

Michael Recht, H. Pöllmann, Annarita Tagliaferri et al. · Haemophilia · 2011 · 44 citations

Life Sciences, Immunology, Pharmacology +10

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

Alpesh Amin, W. Richey Neuman, Melissa Lingohr-Smith et al. · Drugs in Context · 2019 · 30 citations · Full text

Medicine, Health Services Administration, Clinical Epidemiology +16

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Steven Deitelzweig, W. Richey Neuman, Melissa Lingohr-Smith et al. · Journal of Medical Economics · 2017 · 28 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

Alpesh Amin, Steven Deitelzweig, Iwona Bucior et al. · Journal of Medical Economics · 2019 · 15 citations · Full text

Medicine, Insurance, Internal Medicine +17

Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States

Holly Guy, Vicki Laskier, Mark Fisher et al. · PharmacoEconomics · 2018 · 14 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

1–5 of 6